Bio-Optronics unveiled the launch of CCTrialSuite, a comprehensive set of integrated, patient-centric clinical research management products to further streamline research operations while maintaining a high degree of compliance. The company announced the introduction of the first two CCTrialSuite products in the family complementing its industry-leading Clinical Conductor CTMS:
CCPay, a fully integrated comprehensive payment solution offering sites the unprecedented ability to service patients with real-time payment reimbursements using secure pre-paid patient payment cards.
CCText, an advanced text messaging solution for clinical research sites designed to boost patient recruitment, engagement, and retention with 2-way messages to participants. CCText is the only CTMS-integrated, 2-way text messaging solution available to research sites.
“CCTrialSuite is designed to be the first solution in the industry providing the breadth of integrated tools required to run the world’s best research that does not compromise on functional depth,” states Max Elbaz, Chief Commercial Officer at Bio-Optronics.
Focused on dynamic patient-centric needs and coupled with the industry’s most efficient internal business operations capabilities, CCTrialSuite is a solution for research facilities around the world to offer connected applications enhancing trial patients’ experience, supporting research business growth and ensuring compliance.
Central to the CCTrialSuite is the Clinical Conductor CTMS, which is used by thousands of clinical research sites around the world to simplify, standardize complex research processes to expand business efficiencies, compliance and advance patient experience.
Bio-Optronics is highlighting CCTrialSuite at ACRP Annual Conference, April 12-14, in Nashville, TN. All solutions can be seen by visiting booth #134 in the exhibit hall.
For more information, visit www.bio-optronics.com or follow @BioOptronics on Twitter or LinkedIn
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.